Pay in installments of $5.07 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
For Your Every Summer RSVP, with Code: SUMMER15
Description
Does Wegovy Need to Be Refrigerated? Tips for Storing Wegovy GoodRx how long is semaglutide good for in the refrigerator How Long Does Compounded Semaglutide Last in Retatrutide 25mg Research Peptide Laboratory Use, 99% Purity THE SECRET BEAUTY STORE Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care WomanWho Once Weighed 414lbsExplains How Ozempic Has Changed Her Life Newsweek COMPOUNDED SEMAGLUTIDE Fitish




Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.4 ★★★★★
Based on 1229 reviews
Sort
Product Reviews
★★★★★ 5
Heel Fisures
Material Type: Black - 3 Pairs, Size: X-Large
Fantastic product. Worked well beyond my expectations.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 20, 2026
★★★★★ 4
X-Large is about a size 12-13 shoe size foot USA.
Material Type: Black - 3 Pairs, Size: X-Large
I love them they work fantastic. I am a big guy with swollen feet. Wear size 12 to 13 USA Shoes. They fit me just fine not tight. My feet felt good after wearing them for two days. Some dry skin pulled off with them and it says to wash by hand. I dont know about the durability but I am hoping to get about 5 uses per pair. Before they become unusable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 7, 2026
★★★★★ 5
Comfortable
Material Type: Black - 2 Pairs, Size: X-Large, Material Type: Black - 2 Pairs, Size: X-Large
I have very sensitive skin, so I usually need to wear socks at all times. These are especially comfortable because they don’t cover the toes, which helps with temperature control. The material is well-balanced—not too thick or too thin—and has just the right amount of stretch. I also appreciate the large traction area, which adds stability. Another plus is that they are completely fragrance-free.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 21, 2026
★★★★★ 5
Great Heel Socks
Material Type: Black - 3 Pairs, Size: Large
I don't know how they work but it's wonderful. I've had rough heel problems for a long time. I wear these everyday and my heels are not rough. They're not baby bottom smooth, but they are not ever going to be. These heel socks also oncce they are properly positioned snap onto the heel. Properly positioning them is easy when you put them on your foot with the heel cup in the correct orientation.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 14, 2026
★★★★★ 3
Too small
Material Type: Gray - 3 Pairs, Size: X-Large
Too tight! Even size large used for a man with smaller feet is too tight. Also, no instructions for use or care.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 21, 2026
recommand products
The FDA has approved Wegovy® (semaglutide) for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. This makes Wegovy the first GLP-1 receptor agonist approved
22.49
Tamiflu (Oseltamivir): Why This Common Flu Drug May Not Be as Helpful – Revolution Health & Wellness
24.50
Oseltamivir phosphate (Tamiflu) alters neurobehavior of zebrafish larvae by inducing mitochondrial dysfunction
20.20
Wegovy Gets F.D.A. Approval for MASH
23.76
The FDA has approved Wegovy (semaglutide) as a treatment for metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program:
26.52




